Skip to main content

Table 4 Correlations between PPBC and KHQ domain change scores in subjects treated with TER or placebo

From: Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

 

Placebo

TER

KHQ Domain

r

P Value

r

P Value

General Health Perceptions

0.14

0.0038

0.13

0.009

Incontinence Impact

0.41

<0.0001

0.36

<0.0001

Role Limitations

0.31

<0.0001

0.31

<0.0001

Physical Limitations

0.35

<0.0001

0.33

<0.0001

Social Limitations

0.29

<0.0001

0.24

<0.0001

Personal Relationships

0.16

0.0113

0.17

0.0076

Emotions

0.25

<0.0001

0.30

<0.0001

Sleep/Energy

0.22

<0.0001

0.20

<0.0001

Severity/Coping

0.36

<0.0001

0.33

<0.0001

Symptom Severity

0.30

<0.0001

0.38

<0.0001

  1. KHQ = King's Health Questionnaire; PPBC = Patient Perception of Bladder Condition; TER = tolterodine extended release.